TrialJournal of cardiothoracic surgery2011

Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial.

Juan J Jiménez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.